{"id":348023,"date":"2026-03-26T01:40:09","date_gmt":"2026-03-26T01:40:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/348023\/"},"modified":"2026-03-26T01:40:09","modified_gmt":"2026-03-26T01:40:09","slug":"forget-droneshield-and-eos-this-asx-healthcare-stock-is-up-15x-in-a-year","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/348023\/","title":{"rendered":"Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!"},"content":{"rendered":"\n<p>4DMedical Ltd (<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-4dx\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: 4DX<\/a>) shares stole the spotlight on Wednesday, surging 34% to a record high and capping off one of the most extraordinary runs on the ASX.<\/p>\n<p>Over the past year, defence stocks have grabbed the headlines with Droneshield Ltd up 330% and Electro Optic Systems Ltd (<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-eos\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: EOS<\/a>) up 540% but the returns from 4DMedical, up a staggering 1,630%, are hard to ignore.<\/p>\n<p>What is driving such an astronomical share price increase?<\/p>\n<p> <img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"675\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/03\/six-happy-health-workers-16.9-1200x675.jpg\" class=\"attachment-full size-full wp-post-image\" alt=\"Six smiling health workers pose for a selfie.\"  \/><\/p>\n<p>Image source: Getty Images<\/p>\n<p> A major endorsement from Mayo Clinic <\/p>\n<p>The catalyst for the latest move is the deployment of 4DMedical&#8217;s CT:VQ technology at the Mayo Clinic in the United States, widely regarded as one of the best hospitals in the world.<\/p>\n<p>This is a high credibility signal. When an institution like Mayo adopts a new technology, it carries weight across the broader healthcare system.<\/p>\n<p>Mayo will use the technology for ventilation and perfusion analysis, initially integrating it into clinical workflows and evaluating its use across a range of applications.<\/p>\n<p> Building serious momentum <\/p>\n<p>What also stands out is the speed of adoption.<\/p>\n<p>In just seven months since receiving FDA clearance in September 2025, 4DMedical has secured deployments at six leading US academic medical centres, including Stanford, Cleveland Clinic, and the University of Chicago.<\/p>\n<p>That level of traction in such a short timeframe is unusual and suggests strong early demand.<\/p>\n<p>The company&#8217;s value proposition is clear. Its technology eliminates the need for radioisotopes and contrast agents, integrates into existing CT workflows, and delivers high resolution functional imaging.<\/p>\n<p>It also aligns with reimbursement pathways, which is critical for real world adoption.<\/p>\n<p> What investors should watch <\/p>\n<p>There is no doubt that 4DMedical is one of the hottest stocks on the ASX right now. The rally reflects growing confidence that the company is moving beyond a promising technology story into early commercial execution.<\/p>\n<p>With a <a href=\"https:\/\/www.fool.com.au\/definitions\/market-capitalisation\/\" rel=\"nofollow noopener\" target=\"_blank\">market cap<\/a> exceeding $3Billion, expectations are sky high and the next phase is strong execution. Investors will want to see these deployments translate into meaningful revenue and over time, free <a href=\"https:\/\/www.fool.com.au\/definitions\/cash-flow\/\" id=\"https:\/\/www.fool.com.au\/definitions\/cash-flow\/\" rel=\"nofollow noopener\" target=\"_blank\">cash flow<\/a>. <\/p>\n","protected":false},"excerpt":{"rendered":"4DMedical Ltd (ASX: 4DX) shares stole the spotlight on Wednesday, surging 34% to a record high and capping&hellip;\n","protected":false},"author":2,"featured_media":348024,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[134,527,111,139,69],"class_list":["post-348023","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/348023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=348023"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/348023\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/348024"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=348023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=348023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=348023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}